Compounds > organophosphonates
Page last updated: 2024-09-05

organophosphonates and Cancer of Head

organophosphonates has been researched along with Cancer of Head in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (37.50)18.2507
2000's2 (25.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zeitels, SM1
Andrei, G; Mertens, B; Naesens, L; Nogueira, T; Snoeck, R; Stranska, R1
Aaltonen, LM; Andersen, J; Brunings, JW; Chirila, M; de Gier, HH; Dietz, A; Dikkers, FG; Ferran Vilà, F; Friedrich, G; Golusinski, W; Graupp, M; Hantzakos, A; Horcasitas, R; Ilmarinen, T; Jackowska, J; Koelmel, JC; Lawson, G; Lindner, F; Remacle, M; Sittel, C; Tjon Pian Gi, RE; van den Heuvel, ER; Weichbold, V; Wierzbicka, M1
Ferris, RL; Sirianni, N; Wang, J1
Benson, AB; Blough, R; French, S; Kies, M; Kilton, LJ; Lad, T; Mullane, M; Rosen, F; Vokes, EE; Wade, J1
Adams, GL; Dutcher, JP; Leaf, AN; Neuberg, D; Ritch, PS; Schwartz, EL; Wadler, S1
Abdulkarim, B; Bourhis, J; Chagraoui, H; Chouaïb, S; Deutsch, E; Eschwege, F; Maggiorella, L; Sabri, S; Thierry, J; Vainchenker, W1
Body, JJ; Delmas, PD1

Trials

2 trial(s) available for organophosphonates and Cancer of Head

ArticleYear
Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck. An Illinois Cancer Center study.
    Investigational new drugs, 1995, Volume: 13, Issue:3

    Topics: Adenine; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Organophosphonates; Treatment Outcome

1995
An ECOG phase II study of amonafide in unresectable or recurrent carcinoma of the head and neck (PB390). Eastern Cooperative Oncology Group.
    Investigational new drugs, 1997, Volume: 15, Issue:2

    Topics: Adenine; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Organophosphonates

1997

Other Studies

6 other study(ies) available for organophosphonates and Cancer of Head

ArticleYear
Glottic Cancer: A Metamorphosing Disease.
    The Annals of otology, rhinology, and laryngology, 2016, Volume: 125, Issue:6

    Topics: Adolescent; Adult; Antiviral Agents; Carcinoma, Squamous Cell; Cidofovir; Cytosine; Diagnostic Errors; Female; Glottis; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Laryngoscopy; Laser Therapy; Lasers, Solid-State; Male; Middle Aged; Organophosphonates; Papillomavirus Infections; Respiratory Tract Infections; Retrospective Studies; Smoking; Squamous Cell Carcinoma of Head and Neck

2016
Cidofovir is active against human papillomavirus positive and negative head and neck and cervical tumor cells by causing DNA damage as one of its working mechanisms.
    Oncotarget, 2016, Jul-26, Volume: 7, Issue:30

    Topics: Antiviral Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cidofovir; Cytosine; DNA Damage; Female; Head and Neck Neoplasms; HeLa Cells; Humans; Male; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Squamous Cell Carcinoma of Head and Neck; Uterine Cervical Neoplasms

2016
Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2013, Volume: 270, Issue:5

    Topics: Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytosine; Female; Head and Neck Neoplasms; Humans; Injections, Intralesional; Male; Neutropenia; Off-Label Use; Organophosphonates; Papillomavirus Infections; Renal Insufficiency; Respiratory Tract Infections; Retrospective Studies; Treatment Outcome

2013
Antiviral activity of Cidofovir on a naturally human papillomavirus-16 infected squamous cell carcinoma of the head and neck (SCCHN) cell line improves radiation sensitivity.
    Oral oncology, 2005, Volume: 41, Issue:4

    Topics: Adult; Antiviral Agents; Blotting, Western; Carcinoma, Squamous Cell; Cell Survival; Cidofovir; Cytosine; Head and Neck Neoplasms; Humans; Male; Neoplasm Proteins; Oncogene Proteins, Viral; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Radiation Tolerance; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2005
Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers.
    Oncogene, 2002, Apr-04, Volume: 21, Issue:15

    Topics: Animals; Antiviral Agents; Carcinoma; Cell Division; Cidofovir; Cyclin A; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytosine; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Oncogene Proteins, Viral; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Radiation-Sensitizing Agents; Radiation, Ionizing; Retinoblastoma Protein; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Virus Infections; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays

2002
Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemia.
    The Journal of clinical endocrinology and metabolism, 1992, Volume: 74, Issue:3

    Topics: Amino Acids; Biomarkers; Bone Resorption; Breast Neoplasms; Calcium; Female; Head and Neck Neoplasms; Humans; Hypercalcemia; Male; Middle Aged; Neoplasms; Organophosphonates

1992